European Pharmaceutical Drugs Market Expected to Reach USD 219.9 Billion at 4.5% CAGR by 2027 | Future growth prospects, share value, major key players and industry dynamics

0

Europe Pharmaceutical Drugs Market, through Drug type (generic drugs and brand name drugs), by product type (prescription drugs and over the counter drugs), by application (cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, central nervous system, genitourinary -urinary, gastrointestinal, respiratory, hematology, dermatology, ophthalmology and others), by distribution channel (hospital pharmacy, retail pharmacy and online pharmacy) and by country / region (Germany, France, United Kingdom, Italy, Spain, Russia, Netherlands, Poland, Switzerland, Sweden and rest of Europe) was estimated to be $ 219.9 billion in 2019, and is expected to post a CAGR of 4.5% over the forecast period (2019 – 2027), as highlighted in a new report released by Coherent Market Insights.

Request a Free PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3541

The expiration of the patents of the main branded products paves the way for generics, which in turn are expected to propel the growth of the European pharmaceutical device market

The pharmaceutical drug market is expected to experience significant growth in the near future, due to the expiration of patents for major pharmaceuticals. Generic products are economically priced and more affordable. A large number of companies introduce these products to the world market, thus contributing to the high volume of sales. Hence, it has created lucrative opportunities for market players by providing the generic formulation of the drug at low cost. For example, cetuximab (Erbitux) is an epidermal growth factor receptor inhibitor indicated for the treatment of metastatic colorectal cancer and head and neck cancer. It is manufactured under patent by Bristol-Myers Squibb and Eli Lily Company in Europe. The drug’s patent expired in 2018 and should therefore provide an opportunity for a large number of market players to manufacture the generic version.

In addition, increased mergers and acquisitions are expected to drive the growth of the European pharmaceutical pharmaceutical devices market during the forecast period. For example, in August 2018, Novo Nordisk completed the acquisition of UK diabetes drug maker Ziylo. The acquisition is expected to expand Novo Nordisk’s product portfolio for the treatment of diabetes.

Browse 30 tables of market data and 38 figures spread over 199 pages and an in-depth table of contents on the “European market for pharmaceutical drugs” – European forecasts until 2027, through Drug type (generic drugs and brand name drugs), by product type (prescription drugs and over the counter drugs), by application (cardiovascular, musculoskeletal, oncology, anti-infective, metabolic disorder, central nervous system, genitourinary -urinary, gastrointestinal, respiratory, hematology, dermatology, ophthalmology and others), by distribution channel (hospital pharmacy, retail pharmacy and online pharmacy) and by country / region (Germany, France, United Kingdom, Italy, Spain, Russia, Netherlands, Poland, Switzerland, Sweden and rest of Europe)

To know the latest trends and information prevailing in the Negative Pressure Therapy Market Press Release, click on the link below: https://www.coherentmarketinsights.com/press-release/europe-pharmaceutical-drugs-market-2860

The increasing incidence of chronic diseases is expected to drive the market growth. For example, in recent years there has been an increase in the number of people diagnosed with diabetes in Europe, which is expected to drive demand for branded and generic drugs. For example, in 2019, according to reports from the International Diabetes Federation, the prevalence of diabetes in Europe is expected to drop from 6.3% in 2019 to around 7.8% by 2045.

Major market players are focused on adopting expansion strategies such as partnerships and acquisitions to expand their product portfolio and geographic position in the European pharmaceutical drugs market. For example, in January 2020, Boehringer Ingelheim entered into a strategic partnership with PhoreMost Limited, a UK-based biopharmaceutical company, for the development of new therapies.

Purchase this report (price $ 4,500 for a single user license) @ https://www.coherentmarketinsights.com/insight/buy-now/3541

Key Points of the Negative Pressure Wound Therapy Market:

  • The European pharmaceutical drugs market is expected to post a CAGR of 4.5% during the forecast period, owing to the increasing incidence of diseases, M&A spending and products. For example, in January 2019, Takeda Pharmaceutical Company Limited acquired Shire plc. The acquisition is expected to increase Takeda’s presence in the European market.
  • Among drug types, branded segment is expected to dominate the European pharmaceutical drug market in 2018 due to the increasing prevalence of chronic diseases and growing strategic collaboration. For example, according to reports released by the World Health Organization in 2017, around 10% of men and almost 9% of women in the age group 25 and over have diabetes.
  • Among product types, the prescription drug segment is expected to show a higher CAGR during the forecast period due to the increase in strategic partnerships among manufacturers to strengthen their market presence. For example, in December 2019, Pfizer Inc. and GlaxoSmithKline entered into a strategic agreement to combine their consumer healthcare units to form a joint venture to focus more on prescription drugs.
  • Among the application types, the oncology segment is expected to dominate the European pharmaceutical drugs market in 2019, due to the increasing patient population. For example, in 2018, according to the World Health Organization, cervical cancer is one of the most common types of cancer affecting women in Europe, with around 69,000 new cases each year. Therefore, increasing patient population is expected to drive the demand for pharmaceutical drugs in Europe during the forecast period.
  • Major players operating in the European pharmaceutical drugs market include Allergan plc. , Novo Nordisk, Boehringer Ingelheim, Merck KGaA, GlaxoSmithKline Plc. , AstraZeneca Plc, Baxter AG, Novartis AG, F. Hoffmann-La Roche Ltd, Shire and Sanofi.

Detailed segmentation:

  • European market for pharmaceutical drugs, by type of drug:
    • Generic drugs
    • Brand name drugs
  • Global Pharmaceutical Drugs Market in Europe, By Product Type:
    • Prescription drugs
    • Over-the-counter (OTC) drugs
  • Global Pharmaceutical Drugs Market in Europe, By Application:
    • Cardiovascular
    • Musculoskeletal
    • Oncology
    • Anti-infectives
    • Metabolic disorder
    • Central nervous system
    • Genitourinary
    • Gastrointestinal
    • Respiratory
    • Hematology
    • Dermatology
    • Ophthalmology
    • Others
  • Global Pharmaceutical Drugs Market in Europe, by Distribution Channel:
    • Hospital pharmacy
    • Retail pharmacy
    • Online pharmacy
  • Global Pharmaceutical Drugs Market in Europe, By Country / Region:
    • UK
      • By type of drug:
        • Generic drugs
        • Brand name drugs
      • By product type:
        • Prescription drugs
        • Over-the-counter (OTC) drugs
      • By application
        • Cardiovascular
        • Musculoskeletal
        • Oncology
        • Anti-infectives
        • Metabolic disorder
        • Central nervous system
        • Genitourinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By distribution channel
        • Hospital pharmacy
        • Retail pharmacy
        • Online pharmacy
    • Germany
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • France
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • Italy
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • Spain
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • Russia
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • Netherlands
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • Poland
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • Switzerland
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • Sweden
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
    • The rest of europe
      • By type of drug:
      • By product type:
      • By application
      • By distribution channel
  • Company Profiles
    • Allergan plc. *
      • Company presentation
      • Product portfolio
      • Financial performance
      • Highlights
      • Market strategies
    • Novo Nordisk
    • Boehringer Ingelheim
    • Merck KGaA
    • GlaxoSmithKline Plc.
    • AstraZeneca Plc
    • Baxter SA
    • Novartis AG
    • Hoffmann-La Roche SA
    • County
    • Sanofi.

About Coherent Market Insights:

Coherent Market Insights is a leading market research and consulting firm providing action-ready syndicated research reports, personalized market analysis, advisory services and competitive analysis through various recommendations related to emerging market trends , technologies and potential opportunities in absolute dollars.

Contact us:
[email protected]

American office:
Name: Mr. Shah
Consistent outlook for the 1001 4th Ave market,
# 3200 Seattle, WA 98154, USA
United States: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
JAPAN: + 050-5539-1737


Source link

Share.

Comments are closed.